Correlation of Three Immunohistochemically Detected Markers of Neuroendocrine Differentiation With Clinical Predictors of Disease Progression in Prostate Cancer

BMC Urology - United Kingdom
doi 10.1186/1471-2490-8-21
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Molecular Model for Neuroendocrine Prostate Cancer Progression

BJU International
Urology
2018English

Is HOTAIR Really Involved in Neuroendocrine Prostate Cancer Differentiation?

Epigenomics
Cancer ResearchGenetics
2018English

Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer: A Case Report

Molecular and Clinical Oncology
Cancer ResearchOncology
2015English

Breast Cancer With Neuroendocrine Differentiation Detected by Unique Staining Pattern of Neoplastic Cells in Hercep Test

Journal of Nippon Medical School
Medicine
2004English

Prostate Cancer and Neuroendocrine Differentiation: More Neuronal, Less Endocrine?

Frontiers in Oncology
Cancer ResearchOncology
2015English

The Relationship of Palliative Transurethral Resection of the Prostate With Disease Progression in Patients With Prostate Cancer

BJU International
Urology
2010English

Models of Neuroendocrine Prostate Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2014English

Methylation in Benign Prostate and Risk of Disease Progression in Men Subsequently Diagnosed With Prostate Cancer

International Journal of Cancer
Cancer ResearchOncology
2016English

The Cannabinoid WIN 55,212-2 Prevents Neuroendocrine Differentiation of LNCaP Prostate Cancer Cells

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy